Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus

P. Kempler, A. Stirban, S. Tesfaye, L. Czupryniak, I. Gurieva, B. N. Mankovsky, V. Spallone, I. A. Veresiu, O. Schnell

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Peripheral and/or autonomous neuropathy is associated with increased cardiovascular risk in diabetes patients. One of the common pathogenetic factors is increased production of free oxygen radicals and their derivatives; a hyperglycaemic metabolism impairs endoneural blood perfusion, leading to neuronal cell damage as typical in diabetic neuropathy. The aim of pathogenetically oriented treatment is to slow down, stop, or reverse the progression of neuropathic damage, and clear indications show that benfotiamine and alpha-lipoic acid along with blood glucose optimization and risk factor management may have a positive effect on the processes involved in neuropathy. Benfotiamine inhibits pathways involved in developing neuropathy while stimulating pathways that play a role in improving neuropathy, such as the pentose-phosphate shunt. Alpha-lipoic acid - an effective antioxidant - may partly inhibit pathogenetic processes caused by oxidative stress. Both of these substances have been shown better tolerance profiles than drugs aimed at controlling symptoms, and should play a role in treating patients with diabetic neuropathy.

Original languageEnglish
Pages (from-to)143-150
Number of pages8
JournalDiabetes, Stoffwechsel und Herz
Volume20
Issue number3
Publication statusPublished - May 20 2011

Fingerprint

Thioctic Acid
Diabetic Neuropathies
Diabetes Mellitus
Drug Tolerance
Pentose Phosphate Pathway
Risk Management
Free Radicals
Blood Glucose
Reactive Oxygen Species
Oxidative Stress
Perfusion
Antioxidants
Therapeutics
benphothiamine

Keywords

  • Benfotiamine
  • Diabetes
  • Diabetic neuropathy
  • Metabolism
  • Oxidative stress

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Kempler, P., Stirban, A., Tesfaye, S., Czupryniak, L., Gurieva, I., Mankovsky, B. N., ... Schnell, O. (2011). Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus. Diabetes, Stoffwechsel und Herz, 20(3), 143-150.

Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus. / Kempler, P.; Stirban, A.; Tesfaye, S.; Czupryniak, L.; Gurieva, I.; Mankovsky, B. N.; Spallone, V.; Veresiu, I. A.; Schnell, O.

In: Diabetes, Stoffwechsel und Herz, Vol. 20, No. 3, 20.05.2011, p. 143-150.

Research output: Contribution to journalArticle

Kempler, P, Stirban, A, Tesfaye, S, Czupryniak, L, Gurieva, I, Mankovsky, BN, Spallone, V, Veresiu, IA & Schnell, O 2011, 'Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus', Diabetes, Stoffwechsel und Herz, vol. 20, no. 3, pp. 143-150.
Kempler P, Stirban A, Tesfaye S, Czupryniak L, Gurieva I, Mankovsky BN et al. Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus. Diabetes, Stoffwechsel und Herz. 2011 May 20;20(3):143-150.
Kempler, P. ; Stirban, A. ; Tesfaye, S. ; Czupryniak, L. ; Gurieva, I. ; Mankovsky, B. N. ; Spallone, V. ; Veresiu, I. A. ; Schnell, O. / Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus. In: Diabetes, Stoffwechsel und Herz. 2011 ; Vol. 20, No. 3. pp. 143-150.
@article{652080fd57f849c0957c9113407e7e9d,
title = "Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus",
abstract = "Peripheral and/or autonomous neuropathy is associated with increased cardiovascular risk in diabetes patients. One of the common pathogenetic factors is increased production of free oxygen radicals and their derivatives; a hyperglycaemic metabolism impairs endoneural blood perfusion, leading to neuronal cell damage as typical in diabetic neuropathy. The aim of pathogenetically oriented treatment is to slow down, stop, or reverse the progression of neuropathic damage, and clear indications show that benfotiamine and alpha-lipoic acid along with blood glucose optimization and risk factor management may have a positive effect on the processes involved in neuropathy. Benfotiamine inhibits pathways involved in developing neuropathy while stimulating pathways that play a role in improving neuropathy, such as the pentose-phosphate shunt. Alpha-lipoic acid - an effective antioxidant - may partly inhibit pathogenetic processes caused by oxidative stress. Both of these substances have been shown better tolerance profiles than drugs aimed at controlling symptoms, and should play a role in treating patients with diabetic neuropathy.",
keywords = "Benfotiamine, Diabetes, Diabetic neuropathy, Metabolism, Oxidative stress",
author = "P. Kempler and A. Stirban and S. Tesfaye and L. Czupryniak and I. Gurieva and Mankovsky, {B. N.} and V. Spallone and Veresiu, {I. A.} and O. Schnell",
year = "2011",
month = "5",
day = "20",
language = "English",
volume = "20",
pages = "143--150",
journal = "Diabetes und Stoffwechsel",
issn = "1861-7603",
publisher = "Verlag Kirchheim and Co. GmbH",
number = "3",

}

TY - JOUR

T1 - Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus

AU - Kempler, P.

AU - Stirban, A.

AU - Tesfaye, S.

AU - Czupryniak, L.

AU - Gurieva, I.

AU - Mankovsky, B. N.

AU - Spallone, V.

AU - Veresiu, I. A.

AU - Schnell, O.

PY - 2011/5/20

Y1 - 2011/5/20

N2 - Peripheral and/or autonomous neuropathy is associated with increased cardiovascular risk in diabetes patients. One of the common pathogenetic factors is increased production of free oxygen radicals and their derivatives; a hyperglycaemic metabolism impairs endoneural blood perfusion, leading to neuronal cell damage as typical in diabetic neuropathy. The aim of pathogenetically oriented treatment is to slow down, stop, or reverse the progression of neuropathic damage, and clear indications show that benfotiamine and alpha-lipoic acid along with blood glucose optimization and risk factor management may have a positive effect on the processes involved in neuropathy. Benfotiamine inhibits pathways involved in developing neuropathy while stimulating pathways that play a role in improving neuropathy, such as the pentose-phosphate shunt. Alpha-lipoic acid - an effective antioxidant - may partly inhibit pathogenetic processes caused by oxidative stress. Both of these substances have been shown better tolerance profiles than drugs aimed at controlling symptoms, and should play a role in treating patients with diabetic neuropathy.

AB - Peripheral and/or autonomous neuropathy is associated with increased cardiovascular risk in diabetes patients. One of the common pathogenetic factors is increased production of free oxygen radicals and their derivatives; a hyperglycaemic metabolism impairs endoneural blood perfusion, leading to neuronal cell damage as typical in diabetic neuropathy. The aim of pathogenetically oriented treatment is to slow down, stop, or reverse the progression of neuropathic damage, and clear indications show that benfotiamine and alpha-lipoic acid along with blood glucose optimization and risk factor management may have a positive effect on the processes involved in neuropathy. Benfotiamine inhibits pathways involved in developing neuropathy while stimulating pathways that play a role in improving neuropathy, such as the pentose-phosphate shunt. Alpha-lipoic acid - an effective antioxidant - may partly inhibit pathogenetic processes caused by oxidative stress. Both of these substances have been shown better tolerance profiles than drugs aimed at controlling symptoms, and should play a role in treating patients with diabetic neuropathy.

KW - Benfotiamine

KW - Diabetes

KW - Diabetic neuropathy

KW - Metabolism

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=79957938119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957938119&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:79957938119

VL - 20

SP - 143

EP - 150

JO - Diabetes und Stoffwechsel

JF - Diabetes und Stoffwechsel

SN - 1861-7603

IS - 3

ER -